The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 29, 2018
Filed:
Jul. 31, 2015
Applicants:
3m Innovative Properties Company, St. Paul, MN (US);
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
John Vasilakos, Woodbury, MN (US);
Willem Overwijk, Houston, TX (US);
Assignees:
3M INNOVATIVE PROPERTIES COMPANY, St. Paul, MN (US);
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 39/395 (2006.01); A61K 31/4745 (2006.01); A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 47/44 (2017.01); A61K 47/10 (2017.01); A61K 9/127 (2006.01); A61K 9/19 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4745 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/127 (2013.01); A61K 9/19 (2013.01); A61K 39/39558 (2013.01); A61K 47/10 (2013.01); A61K 47/44 (2013.01); A61K 2039/505 (2013.01);
Abstract
Methods and therapeutic combinations useful for increasing cell-mediated anti-tumor responses are described. The methods include administering to a subject a therapeutically effective amount of an Immune Response Modifier Compound and a therapeutically effective amount of one or more immune checkpoint inhibitor compounds.